Request for Covid-19 Impact Assessment of this Report

Medical Devices

Europe Immunoassay Reagents and Devices Market - Industry Trends and Forecast To 2027

  • DAT3435546
  • 130 Pages
  • December 2019
  • Medical Devices
Download Sample    Get Discount   
 
Europe immunoassay reagents and devices market is projected to register a substantial CAGR in the forecast period 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

By Product (Reagents & Kits, Analyzers), Platform (Enzyme Immunoassay, Fluorescence Immunoassays, Chemiluminescence Immunoassays, Radioimmunoassays, Others), Technique (Enzyme-Linked Immunosorbent Assays, Enzyme-Linked Immunospot, Rapid Tests, Western Blotting, Immuno-PCR, Other), Specimen Type (Blood, Urine, Saliva, Others), Application (Oncology and Endocrinology, Hematology & Blood Screening, Cardiology, Infectious Diseases, Bone & Mineral Disorders, Autoimmune Disorders, Toxicology, Neonatal Screening, Other Applications), End User (Pharmaceutical And BioTechnique Companies, Clinical Laboratories, Hospitals, Research & Academic Laboratories, Blood Banks, Others), Country (Germany, U.K., Italy, France, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey, Rest of Europe) Market Trends and Forecast to 2027

Some of the major factors contributing to the growth of Europe immunoassay reagents and devices market:

 Increasing prevalence of diseases

 Increasing application of drug screening tests

Market Players:

The key market players for Europe immunoassay reagents and devices market are listed below:

• F. Hoffmann-La Roche Ltd

• Siemens

• Randox Laboratories Ltd

• Abbott, Bio-Rad Laboratories, Inc

• Merck KGaA

• Beckman Coulter, Inc (a subsidiary of Danaher)

• Sysmex Corporation

• bioMérieux SA

• Thermo Fisher Scientific, Inc

• BD

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd

• DiaSorin S.p.A.

• Ortho Clinical Diagnostics (a subsidiary of Carlyle Investment Management L.L.C)

• QIAGEN

• Quidel Corporation

• BioCheck, Inc

• Bio-Techne

• PerkinElmer Inc

• Agilent Technologies, Inc

• Luminex Corporation

• MESO SCALE DIAGNOSTICS, LLC

TABLE OF CONTENTS

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 DBMR MARKET POSITION GRID

2.7 DBMR VENDOR SHARE ANALYSIS

2.8 MULTIVARIATE MODELING

2.9 PRODUCT TIMELINE CURVE

2.10 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 INDUSTRY INSIGHT

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 INCREASING PREVALENCE OF DISEASES

5.1.2 INCREASING APPLICATION OF DRUG SCREEINING TESTS

5.1.3 INCREASING HEALTHCARE EXPENDITURE

5.1.4 WIDE APPLICATION OF IMMUNOASSAY

5.2 RESTRAINTS

5.2.1 PRODUCT RECALL OF IMMUNOASSAY KITS AND DEVICES

5.2.2 STRINGENT REGULATIONS BY REGULATORY AUTHORITIES

5.2.3 HIGH COST ASSOCIATED WITH DEVICES

5.3 OPPORTUNITIES

5.3.1 INCREASE IN RESEARCH & DEVELOPMENT ACTIVITIES

5.3.2 STRATEGIC INITATIVES BY THE COMPANIES

5.3.3 TECHNOLOGICAL UPGRADATION AND ADVANCEMENTS IN BIOTECHNOLOGY

5.4 CHALLENGES

5.4.1 LACK OF AWARENESS AND SKILLS REGARDING THE USAGE OF TECHNOLOGY

5.4.2 COMPLEXICITY IN PERFORMING IMMUNOASSAY

5.4.3 AVAILABILITY OF SUBSTITUTE

6 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 REAGENTS & KITS

6.2.1 ELISA REAGENTS & KITS

6.2.1.1 THIRD-GENERATION ELISA

6.2.1.2 FIFTH-GENERATION ELISA

6.2.1.3 FOURTH-GENERATION ELISA

6.2.1.4 FIRST-GENERATION ELISA

6.2.1.5 SECOND-GENERATION ELISA

6.2.2 ELISPOT REAGENTS & KITS

6.2.3 RAPID TEST REAGENTS & KITS

6.2.4 WESTERN BLOT REAGENTS & KITS

6.2.5 OTHER REAGENTS & KITS

6.3 ANALYZERS

6.3.1 BY TYPE

6.3.1.1 OPEN-ENDED SYSTEMS

6.3.1.2 CLOSED-ENDED SYSTEMS

6.3.2 BY DEVICE TYPE

6.3.2.1 BENCH-TOP

6.3.2.2 FLOOR STANDING

7 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM

7.1 OVERVIEW

7.2 ENZYME IMMUNOASSAY

7.3 FLUORESCENCE IMMUNOASSAYS

7.4 CHEMILUMINESCENCE IMMUNOASSAYS

7.5 RADIOIMMUNOASSAYS

7.6 OTHERS

8 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE

8.1 OVERVIEW

8.2 ENZYME-LINKED IMMUNOSORBENT ASSAYS

8.3 ENZYME-LINKED IMMUNOSPOT

8.4 RAPID TESTS

8.5 WESTERN BLOTTING

8.6 IMMUNO-PCR

8.7 OTHER TECHNIQUES

9 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE

9.1 OVERVIEW

9.2 BLOOD

9.3 URINE

9.4 SALIVA

9.5 OTHERS

10 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 ONCOLOGY AND ENDOCRINOLOGY

10.3 HEMATOLOGY & BLOOD SCREENING

10.4 CARDIOLOGY

10.5 INFECTIOUS DISEASES

10.6 BONE & MINERAL DISORDERS

10.7 AUTOIMMUNE DISORDERS

10.8 TOXICOLOGY

10.9 NEONATAL SCREENING

10.10 OTHER APPLICATIONS

11 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER

11.1 OVERVIEW

11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

11.3 CLINICAL LABORATORIES

11.4 HOSPITALS

11.5 RESEARCH & ACADEMIC LABORATORIES

11.6 BLOOD BANKS

11.7 OTHERS

12 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY GEOGRAPHY

12.1 EUROPE

12.1.1 GERMANY

12.1.2 FRANCE

12.1.3 U.K.

12.1.4 ITALY

12.1.5 SPAIN

12.1.6 RUSSIA

12.1.7 NETHERLANDS

12.1.8 SWITZERLAND

12.1.9 BELGIUM

12.1.10 TURKEY

12.1.11 REST OF EUROPE

13 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: EUROPE

14 COMPANY PROFILES

14.1 F. HOFFMANN-LA ROCHE LTD

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENT

14.2 BIO-RAD LABORATORIES, INC.

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 BIOMÉRIEUX SA

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENT

14.4 ABBOTT

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENTS

14.5 RANDOX LABORATORIES LTD.

14.5.1 COMPANY SNAPSHOT

14.5.2 PRODUCT PORTFOLIO

14.5.3 RECENT DEVELOPMENT

14.6 AGILENT TECHNOLOGIES, INC.

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 PRODUCT PORTFOLIO

14.6.4 RECENT DEVELOPMENT

14.7 LUMINEX CORPORATION

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENT

14.8 BD

14.8.1 COMPANY SNAPSHOT

14.8.2 REVENUE ANALYSIS

14.8.3 PRODUCT PORTFOLIO

14.8.4 RECENT DEVELOPMENT

14.9 BECKMAN COULTER, INC.

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT DEVELOPMENT

14.10 BIOCHECK, INC.

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENT

14.11 BIO-TECHNE

14.11.1 COMPANY SNAPSHOT

14.11.2 REVENUE ANALYSIS

14.11.3 PRODUCT PORTFOLIO

14.11.4 RECENT DEVELOPMENTS

14.12 DIASORIN S.P.A.

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 MERCK KGAA

14.13.1 COMPANY SNAPSHOT

14.13.2 REVENUE ANALYSIS

14.13.3 PRODUCT PORTFOLIO

14.13.4 RECENT DEVELOPMENTS

14.14 MESO SCALE DIAGNOSTICS, LLC

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENTS

14.15 ORTHO CLINICAL DIAGNOSTICS (A SUBSIDIARY OF CARLYLE INVESTMENT MANAGEMENT L.L.C)

14.15.1 COMPANY SNAPSHOT

14.15.2 REVENUE ANALYSIS

14.15.3 PRODUCT PORTFOLIO

14.15.4 RECENT DEVELOPMENT

14.16 PERKINELMER INC.

14.16.1 COMPANY SNAPSHOT

14.16.2 REVENUE ANALYSIS

14.16.3 PRODUCT PORTFOLIO

14.16.4 RECENT DEVELOPMENT

14.17 QIAGEN

14.17.1 COMPANY SNAPSHOT

14.17.2 REVENUE ANALYSIS

14.17.3 PRODUCT PORTFOLIO

14.17.4 RECENT DEVELOPMENT

14.18 QUIDEL CORPORATION

14.18.1 COMPANY SNAPSHOT

14.18.2 REVENUE ANALYSIS

14.18.3 PRODUCT PORTFOLIO

14.18.4 RECENT DEVELOPMENT

14.19 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.20 SIEMENS

14.20.1 COMPANY SNAPSHOT

14.20.2 REVENUE ANALYSIS

14.20.3 PRODUCT PORTFOLIO

14.20.4 RECENT DEVELOPMENTS

14.21 SYSMEX CORPORATION

14.21.1 COMPANY SNAPSHOT

14.21.2 REVENUE ANALYSIS

14.21.3 PRODUCT PORTFOLIO

14.21.4 RECENT DEVELOPMENTS

14.22 THERMO FISHER SCIENTIFIC INC.

14.22.1 COMPANY SNAPSHOT

14.22.2 REVENUE ANALYSIS

14.22.3 PRODUCT PORTFOLIO

14.22.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

LIST OF TABLES

UU

TABLE 1 COST OF EIA KITS BY MERCK KGAA

TABLE 2 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 3 EUROPE REAGENTS AND KITS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 4 EUROPE REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 5 EUROPE REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 6 EUROPE ANALYZERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 7 EUROPE ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 8 EUROPE ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 9 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 10 EUROPE ENZYME IMMUNOASSAY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 EUROPE FLUORESCENCE IMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 EUROPE CHEMILUMINESCENCE IMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 EUROPE RADIOIMMUNOASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 EUROPE OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 16 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAYS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 EUROPE ENZYME-LINKED IMMUNOSPOT IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 EUROPE RAPID TESTS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 EUROPE WESTERN BLOTTING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 EUROPE IMMUNO-PCR IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 21 EUROPE OTHER TECHNIQUES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 23 EUROPE BLOOD IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 EUROPE URINE IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 EUROPE SALIVA IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 26 EUROPE OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 27 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 28 EUROPE ONCOLOGY AND ENDOCRINOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 EUROPE HEMATOLOGY & BLOOD SCREENING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 30 EUROPE CARDIOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 31 EUROPE INFECTIOUS DISEASES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 32 EUROPE BONE & MINERAL DISORDERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 33 EUROPE AUTOIMMUNE DISORDERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 34 EUROPE TOXICOLOGY IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 35 EUROPE NEONATAL SCREENING IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 36 EUROPE OTHER APPLICATIONS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 37 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 38 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 39 EUROPE CLINICAL LABORATORIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 40 EUROPE HOSPITALS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 41 EUROPE RESEARCH & ACADEMIC LABORATORIES IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 42 EUROPE BLOOD BANKS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 43 EUROPE OTHERS IN IMMUNOASSAY REAGEMTS AND DEVICES MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 44 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 45 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 46 EUROPE ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 47 EUROPE ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 48 EUROPE REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 49 EUROPE ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 50 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 51 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 52 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 53 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 54 EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 55 GERMANY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 56 GERMANY ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 57 GERMANY ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 58 GERMANY REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 59 GERMANY ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 60 GERMANY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 61 GERMANY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 62 GERMANY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 63 GERMANY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 64 GERMANY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 65 FRANCE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 66 FRANCE ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 67 FRANCE ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 68 FRANCE REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 69 FRANCE ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 70 FRANCE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 71 FRANCE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 72 FRANCE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 73 FRANCE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 74 FRANCE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 75 U.K. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 76 U.K. ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 77 U.K. ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 78 U.K. REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 79 U.K. ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 80 U.K. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 81 U.K. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 82 U.K. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 83 U.K. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 84 U.K. IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 85 ITALY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 86 ITALY ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 87 ITALY ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 88 ITALY REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 89 ITALY ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 90 ITALY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 91 ITALY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 92 ITALY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 93 ITALY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 94 ITALY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 95 SPAIN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 96 SPAIN ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 97 SPAIN ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 98 SPAIN REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 99 SPAIN ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 100 SPAIN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 101 SPAIN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 102 SPAIN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 103 SPAIN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 104 SPAIN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 105 RUSSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 106 RUSSIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 107 RUSSIA ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 108 RUSSIA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 109 RUSSIA ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 110 RUSSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 111 RUSSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 112 RUSSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 113 RUSSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 114 RUSSIA IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 115 NETHERLANDS IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 116 NETHERLANDS ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 117 NETHERLANDS ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 118 NETHERLANDS REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 119 NETHERLANDS ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 120 NETHERLANDS IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 121 NETHERLANDS IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 122 NETHERLANDS IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 123 NETHERLANDS IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 124 NETHERLANDS IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 125 SWITZERLAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 126 SWITZERLAND ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 127 SWITZERLAND ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 128 SWITZERLAND REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 129 SWITZERLAND ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 130 SWITZERLAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 131 SWITZERLAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 132 SWITZERLAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 133 SWITZERLAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 134 SWITZERLAND IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 135 BELGIUM IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 136 BELGIUM ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 137 BELGIUM ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 138 BELGIUM REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 139 BELGIUM ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 140 BELGIUM IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 141 BELGIUM IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 142 BELGIUM IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 143 BELGIUM IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 144 BELGIUM IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 145 TURKEY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 146 TURKEY ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 147 TURKEY ANALYZERS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY DEVICE TYPE, 2018-2027 (USD MILLION)

TABLE 148 TURKEY REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 149 TURKEY ELISA REAGENTS & KITS IN IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 150 TURKEY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PLATFORM, 2018-2027 (USD MILLION)

TABLE 151 TURKEY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 152 TURKEY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY SPECIMEN TYPE, 2018-2027 (USD MILLION)

TABLE 153 TURKEY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 154 TURKEY IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 155 REST OF EUROPE IMMUNOASSAY REAGENTS AND DEVICES MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450